Clearmind Medicine Inc. Common Shares Cash Flow Conversion Efficiency
Clearmind Medicine Inc. Common Shares cash flow conversion efficiency. Based on the latest financial reports, Clearmind Medicine Inc. Common Shares (CMND) has a cash flow conversion efficiency ratio of -0.253x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.08 Million) by net assets ($8.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CMND stock market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Clearmind Medicine Inc. Common Shares (2014–2025)
Cash flow conversion efficiency of Clearmind Medicine Inc. Common Shares from 2014 to 2025. This chart illustrates how Clearmind Medicine Inc. Common Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Clearmind Medicine Inc. Common Shares stock price for real-time trading data and today's change.
Clearmind Medicine Inc. Common Shares Cash Flow Conversion Ratio Explained
Clearmind Medicine Inc. Common Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Clearmind Medicine Inc. Common Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clearmind Medicine Inc. Common Shares ranked by their cash flow conversion efficiency. Review how much free cash does Clearmind Medicine Inc. Common Shares generate to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Boqii Holding Limited
NYSE:BQ
|
0.002x |
|
Domec Compania de Artefactos Domesticos SAIC y F
BA:DOME
|
-0.048x |
|
Alpha Compute Corp
NASDAQ:ALP
|
-0.080x |
|
tokentus investment AG
MU:14D
|
N/A |
|
SMIS Corporation Bhd
KLSE:7132
|
-0.076x |
|
Bulletin Resources Ltd
AU:BNR
|
-0.046x |
|
Streamplay Studio Ltd
AU:SP8
|
-0.037x |
|
Gulf Resources, Inc. (NV) Common Stock
NASDAQ:GURE
|
0.010x |
Annual Cash Flow Conversion Efficiency for Clearmind Medicine Inc. Common Shares (2014–2025)
The table below shows the annual cash flow conversion efficiency of Clearmind Medicine Inc. Common Shares from 2014 to 2025. Also see Clearmind Medicine Inc. Common Shares assets under control for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-10-31 | $1.19 Million | $-4.73 Million | -3.970x | -153.91% |
| 2024-10-31 | $4.33 Million | $-6.76 Million | -1.564x | +75.60% |
| 2023-10-31 | $983.47K | $-6.30 Million | -6.407x | -290.27% |
| 2022-10-31 | $-1.50 Million | $-5.06 Million | 3.368x | +728.19% |
| 2021-10-31 | $3.87 Million | $-2.08 Million | -0.536x | -1.21% |
| 2020-10-31 | $374.78K | $-198.50K | -0.530x | -12.49% |
| 2019-10-31 | $101.63K | $-47.85K | -0.471x | -6.62% |
| 2018-10-31 | $182.24K | $-80.48K | -0.442x | -138.92% |
| 2017-10-31 | $49.36K | $-9.12K | -0.185x | -154.96% |
| 2016-10-31 | $-45.71K | $-15.37K | 0.336x | -81.84% |
| 2015-10-31 | $-21.49K | $-39.81K | 1.852x | +23.23% |
| 2014-10-31 | $-18.64K | $-28.01K | 1.503x | -- |
About Clearmind Medicine Inc. Common Shares
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It d… Read more